Kristina Huber

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 170 citations · Full text

Qualitative change in executive control during childhood and adulthood

Nicolas Chevalier, Kristina Huber, Sandra A. Wiebe et al. · Cognition · 2013 · 75 citations · Full text

Child Psychology, Cognitive Development, Developmental Science +9

Long-term kinetics of Zika virus RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case report

Guenter Froeschl, Kristina Huber, Frank von Sonnenburg et al. · BMC Infectious Diseases · 2017 · 68 citations · Full text

Detection of Viable Mycobacterium ulcerans in Clinical Samples by a Novel Combined 16S rRNA Reverse Transcriptase/IS2404 Real-Time qPCR Assay

Dominik Symank, Richard Odame Phillips, Yaw Ampem Amoako et al. · PLoS neglected tropical diseases · 2012 · 44 citations · Full text

Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease—Towards a Point-of-Care Test

Richard Odame Phillips, Florian Battke, Malkin Bauer et al. · PLoS neglected tropical diseases · 2015 · 41 citations · Full text